Taken together, our study showed that p16-IHC as a single biomarker displays the best diagnostic accuracy for prognosis stratification in oropharyngeal cancer patients, with high expression levels indicating a survival benefit. The gene discussed is CDKN2A; the disease is oropharynx cancer.